Cargando…

Oral Contraceptive and Breast Cancer Risks: a Case Control Study in Six Referral Hospitals in Indonesia

OBJECTIVE: This study aimed to understand the effects of the use of oral contraceptive to breast cancer risk in six referral hospitals in Indonesia. METHODS: The research design was hospital based case-control, conducted in 2013. Population was women patients aged 15 years and above in six cancer-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wahidin, Mugi, Djuwita, Ratna, Adisasmita, Asri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171374/
https://www.ncbi.nlm.nih.gov/pubmed/30139225
http://dx.doi.org/10.22034/APJCP.2018.19.8.2199
_version_ 1783360776134721536
author Wahidin, Mugi
Djuwita, Ratna
Adisasmita, Asri
author_facet Wahidin, Mugi
Djuwita, Ratna
Adisasmita, Asri
author_sort Wahidin, Mugi
collection PubMed
description OBJECTIVE: This study aimed to understand the effects of the use of oral contraceptive to breast cancer risk in six referral hospitals in Indonesia. METHODS: The research design was hospital based case-control, conducted in 2013. Population was women patients aged 15 years and above in six cancer-referral hospitals in five provinces. Total of 762 people were included in this study consisting of 381 who are diagnosed with breast cancer as confirmed by histopathologic examination in inpatient surgery ward, and 381 people who are not diagnosed with breast cancer based on interview in outpatient surgery ward as control group. A set of data were collected including the use of oral contraceptives, age, early menarche, childbirth status, breastfeeding status, obesity, unhealthy diet, history of benign breast tumors, family history of breast cancer, and age of menopause. RESULT: Results showed that Odds Ratio (OR) of patients using oral contraceptive <6 years was 1.93 (95% CI 1.23 – 3.03) and OR of those using oral contraceptive ≥ 6 years was 2.90 (95% CI 1.65– 5.09) as compared to people who did not use oral contraceptive. CONCLUSION: Use of oral contraceptive in patients was indicated to increase the risk of breast cancer. Longer the duration of using oral contraceptive tend to have higher the risk of breast cancer.
format Online
Article
Text
id pubmed-6171374
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-61713742018-10-15 Oral Contraceptive and Breast Cancer Risks: a Case Control Study in Six Referral Hospitals in Indonesia Wahidin, Mugi Djuwita, Ratna Adisasmita, Asri Asian Pac J Cancer Prev Research Article OBJECTIVE: This study aimed to understand the effects of the use of oral contraceptive to breast cancer risk in six referral hospitals in Indonesia. METHODS: The research design was hospital based case-control, conducted in 2013. Population was women patients aged 15 years and above in six cancer-referral hospitals in five provinces. Total of 762 people were included in this study consisting of 381 who are diagnosed with breast cancer as confirmed by histopathologic examination in inpatient surgery ward, and 381 people who are not diagnosed with breast cancer based on interview in outpatient surgery ward as control group. A set of data were collected including the use of oral contraceptives, age, early menarche, childbirth status, breastfeeding status, obesity, unhealthy diet, history of benign breast tumors, family history of breast cancer, and age of menopause. RESULT: Results showed that Odds Ratio (OR) of patients using oral contraceptive <6 years was 1.93 (95% CI 1.23 – 3.03) and OR of those using oral contraceptive ≥ 6 years was 2.90 (95% CI 1.65– 5.09) as compared to people who did not use oral contraceptive. CONCLUSION: Use of oral contraceptive in patients was indicated to increase the risk of breast cancer. Longer the duration of using oral contraceptive tend to have higher the risk of breast cancer. West Asia Organization for Cancer Prevention 2018 /pmc/articles/PMC6171374/ /pubmed/30139225 http://dx.doi.org/10.22034/APJCP.2018.19.8.2199 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Research Article
Wahidin, Mugi
Djuwita, Ratna
Adisasmita, Asri
Oral Contraceptive and Breast Cancer Risks: a Case Control Study in Six Referral Hospitals in Indonesia
title Oral Contraceptive and Breast Cancer Risks: a Case Control Study in Six Referral Hospitals in Indonesia
title_full Oral Contraceptive and Breast Cancer Risks: a Case Control Study in Six Referral Hospitals in Indonesia
title_fullStr Oral Contraceptive and Breast Cancer Risks: a Case Control Study in Six Referral Hospitals in Indonesia
title_full_unstemmed Oral Contraceptive and Breast Cancer Risks: a Case Control Study in Six Referral Hospitals in Indonesia
title_short Oral Contraceptive and Breast Cancer Risks: a Case Control Study in Six Referral Hospitals in Indonesia
title_sort oral contraceptive and breast cancer risks: a case control study in six referral hospitals in indonesia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171374/
https://www.ncbi.nlm.nih.gov/pubmed/30139225
http://dx.doi.org/10.22034/APJCP.2018.19.8.2199
work_keys_str_mv AT wahidinmugi oralcontraceptiveandbreastcancerrisksacasecontrolstudyinsixreferralhospitalsinindonesia
AT djuwitaratna oralcontraceptiveandbreastcancerrisksacasecontrolstudyinsixreferralhospitalsinindonesia
AT adisasmitaasri oralcontraceptiveandbreastcancerrisksacasecontrolstudyinsixreferralhospitalsinindonesia